NDC 0009-0291 - Heparin Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0009-0291
- Package NDCs from labels
- 0009-0291-01
- Effective date
- 2006-04-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Heparin Sodium Injection, USP | 2006-04-13 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0009-0291-01 | Heparin Sodium | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Heparin Sodium | ACTIVE INGREDIENT | ZZ45AB24CA | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 | |
| Heparin | ACTIVE MOIETY | T2410KM04A | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Heparin Sodium | HEPARIN SODIUM | Northstar Rx LLC | 2edf6d35-5cf3-b7ff-e063-6394a90a4f33 | 2025-02-19 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Sandoz Inc. | 1c634e53-44d6-cdcd-e063-6294a90a92e9 | 2025-02-19 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | McKesson Corporation dba SKY Packaging | 7f05762a-7527-4796-b21e-68277aec379e | 2025-01-21 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| HEPARIN SODIUM | HEPARIN SODIUM | HF Acquisition Co LLC, DBA HealthFirst | 9bd0f982-30f4-4e38-e053-2a95a90a3e15 | 2025-01-08 | Warnings, Adverse reactions | 1362831 |
| Heparin Sodium | HEPARIN SODIUM | Phlow Corporation | cece935c-1c0a-4949-b023-d6df3d53fbfa | 2024-05-16 | Warnings, Adverse reactions | 1361226 |
| HEPARIN SODIUM | HEPARIN SODIUM | HF Acquisition Co LLC, DBA HealthFirst | 971505d4-f78c-6f5d-e053-2995a90a00e0 | 2024-01-29 | Warnings, Adverse reactions | 1362831 |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | a120bdfd-21e1-4024-82a7-13cfeed290c1 | 2024-01-05 | Warnings, Adverse reactions | 1361226 |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | 3facd525-b9ad-46d0-b63e-f13a5f6d591d | 2021-09-01 | Warnings, Adverse reactions | 1361615 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.